Clinical trials
Completed trials in Croatia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
1,015 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 3 |
| 2001 | 9 |
| 2002 | 11 |
| 2003 | 17 |
| 2004 | 31 |
| 2005 | 29 |
| 2006 | 41 |
| 2007 | 53 |
| 2008 | 57 |
| 2009 | 57 |
| 2010 | 50 |
| 2011 | 64 |
| 2012 | 49 |
| 2013 | 50 |
| 2014 | 44 |
| 2015 | 61 |
| 2016 | 52 |
| 2017 | 42 |
| 2018 | 66 |
| 2019 | 51 |
| 2020 | 43 |
| 2021 | 33 |
| 2022 | 33 |
| 2023 | 39 |
| 2024 | 12 |
| 2025 | 5 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 1,015 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hoffmann-La Roche | 56 |
| Novo Nordisk A/S | 53 |
| Pfizer | 41 |
| University of Zagreb | 37 |
| Eli Lilly and Company | 34 |
| Sanofi | 32 |
| Novartis Pharmaceuticals | 29 |
| Boehringer Ingelheim | 28 |
| AbbVie | 24 |
| AstraZeneca | 23 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus, Type 2 | 66 |
| Diabetes Mellitus | 39 |
| Arthritis, Rheumatoid | 36 |
| Schizophrenia | 34 |
| Breast Neoplasms | 32 |
| Colitis, Ulcerative | 30 |
| Multiple Sclerosis | 28 |
| Pulmonary Disease, Chronic Obstructive | 21 |
| Asthma | 20 |
| Atrial Fibrillation | 20 |
Trials
Showing 26 to 50 of 1,015. Each trial links to its page on Pharma Observatory.
915 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.